A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a new study.

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...

Medically reviewed by Mary Choy, PharmD Amlodipine is a commonly prescribed calcium channel blocker medication used to treat ...

Vascularized composite allotransplantation (VCA) has emerged as a well-established reconstructive method for treating tissue defects. Worldwide, more and more hand and upper extremity VCAs have been ...

Additionally, tumor cells exist in a hostile, immunosuppressive microenvironment that "can ... castration-resistant prostate ...

Many types of medications, including over-the-counter (OTC) and prescription drugs, can help relieve joint pain due to ...

Although individualization is the goal, standardized immunosuppressive regimens consisting of induction and maintenance agents and drugs used for treatment of rejection are generally established ...

Eledon Pharmaceuticals (NASDAQ:ELDN) completed enrollment of its phase 2 BESTOW trial using its immunosuppressive drug tegoprubart for the prevention of organ rejection in patients who undergo ...

In a study presented at the Summit on Stem Cell Derived Islets in Boston, researchers report on encouraging results using an experimental immunosuppressive drug in people with Type 1 diabetes.

The drug, which is currently in Phase 1 testing for cancer in the U.S. and China, is what’s known as a “T cell engager.” It binds to two cell surface proteins called CD19 and CD20, which GSK notes ...